Intellijoint Navigation System: Workstation G2 Configured, REF: 000-0241; Intellijoint HIP Cart System, REF: 000-0250; Intellijoint HIP, Portable System, REF: 000-0249
Published October 14, 2026 · Recall initiated: August 28, 2026
Summary
FDA records medical device Class II recall Z-0119-2027, published October 14, 2026 and initiated August 28, 2026. Recalling firm: Intellijoint Surgical, Inc.; Status: Ongoing; Reported quantity: 8; Lot: REF/UDI-DI/MacBook Serial Numbers: 000-0241/00628184002414/C02RP36YG8WP, C02QPCF5G8WN 000-0250/00628184002506/C02RF44TG8WN, C02QW25RG8WL, C02QH355G8WM, C02S22N9G8WP; 000-0249/00628184002490/C02RQ3FUG8WN, C02R4451G8WN. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
A navigation system used to aid in selection and positioning of orthopedic implant system components has a workstation that may contain a 15-inch MacBook Pro battery, subject to an Apple battery recall, that may overheat and pose a fire safety risk.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Intellijoint Surgical, Inc.
- Distributor
- Worldwide - US Nationwide distribution in the states of CA, TX, MS, NJ and the countries of Singapore, Spain.
- Lot
- REF/UDI-DI/MacBook Serial Numbers: 000-0241/00628184002414/C02RP36YG8WP, C02QPCF5G8WN 000-0250/00628184002506/C02RF44TG8WN, C02QW25RG8WL, C02QH355G8WM, C02S22N9G8WP; 000-0249/00628184002490/C02RQ3FUG8WN, C02R4451G8WN
- Risk classification
- Class II
- Area (FDA)
- device
- Country
- Canada
Related recalls
- FDAMetoclopramide Tablets, USP, 5 mg, [100 or 500] Tablets per bottle, Rx Only, Manufactured for: TevaOctober 21, 2026
- FDAHydrocortisone Sodium Succinate for Injection, USP 100 mg/vial, 1 Vial, Rx Only, Manufactured by: ZydusOctober 21, 2026
- FDATirzepatide/Niacinamide 2mL vial (40 MG per Vial) Inj 20mg/2mg/mL, RX Only, Houston RX LLC, 15430 VantageOctober 21, 2026
- FDAHexaVue Focus Integration System, a single, all-in-one system that handles operating room video routing,October 14, 2026
- FDATufTex® Over-the-Wire Embolectomy Catheter; Catalog Number: E1651-88;October 14, 2026
- FDAT1 Patient Monitor. Operator's Manual: T1 Patient MonitorOctober 14, 2026
Questions about this recall
Was Intellijoint Navigation System: Workstation G2 Configured, REF: 000-0241; Intellijoint HIP Cart System, REF: 000-0250; Intellijoint HIP, Portable System, REF: 000-0249 recalled?
Yes. FDA published recall Z-0119-2027 on October 14, 2026. Reported hazard: A navigation system used to aid in selection and positioning of orthopedic implant system components has a workstation that may contain a 15-inch MacBook Pro battery, subject to an Apple battery recall, that may overheat and pose a fire safety risk.
What should I do if I have this product?
Voluntary: Firm initiated · Letter